GenePlanet, a Ljubjana, Slovenia-based health intelligence company, closed a €10M minority equity funding.
Zurich-based JF Investments AG, owned by Lavinia Jacobs, made the investment.
The funds will be used for product development and international expansion in Asia.
Established in 2008 by its founder Marko Bitenc and co-owned by an investment vehicle controlled by Austrian equity investor Gabriel Dielacher, a former managing director with Creditanstalt Investment Bank (CAIB), GenePlanet specializes in genetic testing and related advanced molecular techniques.
The company offers personalized DNA analyses and commercialises its services and products in over 30 countries worldwide.
One of the key new products will be Health Intelligence – a platform which will be integrating biological data (genetic predispositions and current status of blood biomarkers) with information from smart devices and wearables to provide recommendations and action plans based on objective needs.